BRPI0809958A2 - conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver 5 uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico - Google Patents

conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver 5 uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico

Info

Publication number
BRPI0809958A2
BRPI0809958A2 BRPI0809958A BRPI0809958A2 BR PI0809958 A2 BRPI0809958 A2 BR PI0809958A2 BR PI0809958 A BRPI0809958 A BR PI0809958A BR PI0809958 A2 BRPI0809958 A2 BR PI0809958A2
Authority
BR
Brazil
Prior art keywords
hpv
spheres
strains
differentiating
risk
Prior art date
Application number
Other languages
English (en)
Inventor
Daniel J Park
Karl F Poetter
Zaheer Khan
Original Assignee
Genera Biosystems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genera Biosystems Ltd filed Critical Genera Biosystems Ltd
Publication of BRPI0809958A2 publication Critical patent/BRPI0809958A2/pt
Publication of BRPI0809958B1 publication Critical patent/BRPI0809958B1/pt
Publication of BRPI0809958B8 publication Critical patent/BRPI0809958B8/pt
Publication of BRPI0809958C1 publication Critical patent/BRPI0809958C1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0809958A 2007-04-05 2008-04-04 conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico BRPI0809958C1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US91037307P 2007-04-05 2007-04-05
US91038107P 2007-04-05 2007-04-05
US60/910,381 2007-04-05
US60/910,373 2007-04-05
PCT/US2008/004441 WO2008124091A2 (en) 2007-04-05 2008-04-04 Compositions and methods of detection

Publications (4)

Publication Number Publication Date
BRPI0809958A2 true BRPI0809958A2 (pt) 2008-10-16
BRPI0809958B1 BRPI0809958B1 (pt) 2020-12-01
BRPI0809958B8 BRPI0809958B8 (pt) 2021-06-15
BRPI0809958C1 BRPI0809958C1 (pt) 2021-07-27

Family

ID=39831523

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0809958A BRPI0809958C1 (pt) 2007-04-05 2008-04-04 conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico

Country Status (12)

Country Link
US (2) US8278429B2 (pt)
EP (1) EP2142926B1 (pt)
JP (1) JP2010523114A (pt)
CN (1) CN101730847B (pt)
AU (1) AU2008236678B2 (pt)
BR (1) BRPI0809958C1 (pt)
ES (1) ES2403729T3 (pt)
HK (1) HK1140019A1 (pt)
MX (1) MX2009010751A (pt)
NZ (1) NZ580242A (pt)
RU (1) RU2480732C2 (pt)
WO (1) WO2008124091A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06013728A (es) 2004-05-26 2007-05-09 Genera Biosystems Pty Ltd Biosensor que usa modos por galeria de murmullos en microesferas.
ES2403729T3 (es) * 2007-04-05 2013-05-21 Genera Biosystems Limited Composiciones y métodos de detección
US10679749B2 (en) 2008-08-22 2020-06-09 International Business Machines Corporation System and method for virtual world biometric analytics through the use of a multimodal biometric analytic wallet
WO2011088573A1 (en) * 2010-01-19 2011-07-28 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Set of probes for the detection and typing of 46 human papillomavirus mucosal types
US8263388B2 (en) * 2010-06-10 2012-09-11 The Hong Kong Polytechnic University Method and apparatus for detecting specific DNA sequences
ES2662386T3 (es) * 2011-10-04 2018-04-06 Genera Biosystems Limited Composiciones y métodos para la detección patógenos respiratorios usando sondas de ácido nucleico y subconjuntos de gránulos
EP2798350B1 (en) * 2011-12-29 2021-07-28 Sight Diagnostics Ltd. Methods and systems for detecting a pathogen in a biological sample
AT521238B1 (de) 2018-05-09 2020-02-15 Lifetaq Analytics Gmbh In-situ zellanalyse im zellkultursystem
RU2734957C1 (ru) * 2020-04-20 2020-10-26 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела Уральского отделения Российской академии наук Биомедицинский материал для диагностики патологий в биологических тканях
RU2766938C1 (ru) * 2021-06-30 2022-03-16 Александр Федорович Попов Способ выполнения космохимического исследования

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1276575C (fr) * 1984-11-30 1990-11-20 Sylvie Beaudenon Sondes a papillomavirus et procede de diagnostic in vitro d'infections a papillomavirus
US5411857A (en) * 1985-07-31 1995-05-02 Institut Nationale De La Sante Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections
US5876922A (en) * 1985-07-31 1999-03-02 Institute Pasteur Papillomavirus probe and a process for in vitro diagnosis of papillomavirus infections
DE3779175D1 (de) * 1986-03-21 1992-06-25 Pasteur Institut Bestimmte, von einem papillomavirus-genom abgeleitete dns-sequenzen, deren anwendungen fuer in vitro-diagnostische zwecke und die herstellung von antigenzusammensetzungen.
AU619170B2 (en) * 1987-01-09 1992-01-23 Abbott Laboratories Diagnostic assays using nucleic acid probes
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
CA1339729C (en) * 1988-10-26 1998-03-17 Wayne D. Lancaster Human papillomavirus type 52 dna sequences and methods for employing thesame
US5580970A (en) * 1989-12-01 1996-12-03 Amoco Corporation Detection of HPV transcripts
NL9000134A (nl) * 1990-01-19 1991-08-16 Stichting Res Fonds Pathologie Primers en werkwijze voor het detecteren van humaan papilloma virus genotypen m.b.v. pcr.
US5484699A (en) * 1990-09-28 1996-01-16 Abbott Laboratories Nucleotide sequences useful as type specific probes, PCR primers and LCR probes for the amplification and detection of human papilloma virus, and related kits and methods
FR2670797A1 (fr) * 1990-12-20 1992-06-26 Pasteur Institut Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
DK0523391T3 (da) * 1991-07-13 2003-06-23 Dade Behring Marburg Gmbh Anvendelse af HPV-16 E6 og E7 genafledte peptider til diagnostisk formål
US5346811A (en) * 1991-07-22 1994-09-13 Cerveceria Polar Method and products for human papillomavirus detection
DK0746627T3 (da) * 1994-02-21 2002-12-16 Stichting Res Fonds Pathologie Påvisning af human papillomavirus ved hjælp af en nukleinsyreamplifikationsproces, som anvender generelle primere
CA2163393C (en) * 1994-11-30 2003-04-22 Colleen Marie Nycz Amplification and detection of mycobacteria nucleic acids
US5981180A (en) * 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
JP2000500342A (ja) * 1995-11-15 2000-01-18 ジェン−プローブ・インコーポレーテッド ヒトパピローマウイルス核酸に相補的な核酸プローブおよび関連する方法およびキット
US6511805B1 (en) * 1996-03-15 2003-01-28 The Penn State Research Foundation Methods for detecting papillomavirus DNA in blood plasma and serum
US6265154B1 (en) * 1996-10-25 2001-07-24 Abbott Laboratories Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
DE69806024T2 (de) * 1997-09-16 2003-02-13 Delft Diagnostic Laboratory B.V., Delft Erkennung und identifizierung von menschlichem papillomavirus durch pcr und typ-spezifischer reverser hybridisierung
ZA989950B (en) * 1997-11-17 1999-05-04 Akzo Nobel Nv Transcription based amplification of double stranded DNA targets
CA2378070A1 (en) * 1999-07-19 2001-01-25 Cambridge University Technical Services Limited A method for amplifying low abundance nucleic acid sequences and means for performing said method
US7601497B2 (en) * 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
AU2002230419A1 (en) * 2000-11-08 2002-05-21 Science And Technology Corporation @Unm Fluorescence and fret based assays for biomolecules on beads
CA2457888A1 (en) 2001-08-23 2003-03-06 Merck & Co., Inc. Fluorescent multiplex hpv pcr assays using multiple fluorophores
WO2003054149A2 (en) * 2001-12-07 2003-07-03 University Of Massachusetts Targeted genetic risk-stratification using microarrays
WO2005033333A2 (en) * 2003-10-07 2005-04-14 Dako Denmark A/S Methods and compositions for the diagnosis of cancer
US7901883B2 (en) * 2004-12-10 2011-03-08 Genera Biosystems Limited Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS)
ES2524050T3 (es) * 2004-12-10 2014-12-03 Genera Biosystems Limited Detección del virus del papiloma humano (VPH) usando sondas de ácidos nucleicos, microperlas y clasificadores celulares activados por fluorescencia (FACS)
WO2006066353A1 (en) * 2004-12-23 2006-06-29 Human Genetic Signatures Pty Ltd Detection of human papilloma virus
GB0500996D0 (en) * 2005-01-18 2005-02-23 Delfts Diagnostic Labaratory B Detection method and materials therefor
ES2403729T3 (es) * 2007-04-05 2013-05-21 Genera Biosystems Limited Composiciones y métodos de detección

Also Published As

Publication number Publication date
BRPI0809958B8 (pt) 2021-06-15
WO2008124091A2 (en) 2008-10-16
JP2010523114A (ja) 2010-07-15
RU2480732C2 (ru) 2013-04-27
NZ580242A (en) 2012-02-24
AU2008236678B2 (en) 2013-09-12
EP2142926B1 (en) 2012-12-05
AU2008236678A1 (en) 2008-10-16
HK1140019A1 (en) 2010-09-30
US20100279888A1 (en) 2010-11-04
MX2009010751A (es) 2010-03-08
BRPI0809958B1 (pt) 2020-12-01
EP2142926A4 (en) 2010-08-04
RU2009140736A (ru) 2011-05-10
CN101730847B (zh) 2015-03-18
BRPI0809958C1 (pt) 2021-07-27
US20130184170A1 (en) 2013-07-18
CN101730847A (zh) 2010-06-09
EP2142926A2 (en) 2010-01-13
ES2403729T3 (es) 2013-05-21
US8278429B2 (en) 2012-10-02
WO2008124091A3 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
BRPI0809958A2 (pt) conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver 5 uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico
WO2009019230A3 (en) Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease
WO2011008349A3 (en) Methods of identifying infectious disease and assays for identifying infectious disease
EP3640341A3 (en) Assays to determine dna methylation and dna methylation markers of cancer
WO2009038742A3 (en) Method for estimating risk of acute kidney injury
EP3064584A3 (en) Micro rna-based methods and compositions for the diagnosis, prognosis and treatmentof gastric cancer
WO2008143717A8 (en) Methods of determining lethality of pathogens and malignancies involving replikin peak genes
WO2012012693A3 (en) Methods for detecting signatures of disease or conditions in bodily fluids
WO2008087040A3 (en) Methods and nucleic acids for analyses of cell proliferative disorders
WO2010118035A3 (en) Biomarkers for monitoring treatment of neuropsychiatric diseases
JP2008245635A5 (pt)
WO2009025852A3 (en) Methods of using mirna for detection of in vivo cell death
BR112015004191A2 (pt) chapa de aço
BR112013001020A2 (pt) tira de teste de sangue e sistema de cateter intravenoso
WO2007133682A3 (en) 100% sequence identity detection methods for variable genomes
BRPI0814247A2 (pt) Método para diagnóstico ou classificação de uma infecção por arbovírus, reagentes úteis no dito método e suas aplicações
EP2397229A3 (en) Umbilicus for use in an umbilicus-driven fluid processing system
WO2007109733A3 (en) Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
FR2920311B1 (fr) Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
WO2008008983A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
BR112014024601A2 (pt) oligonucleotídeos modificados compostos de funções tióis e o uso destes para a detecção de ácidos nucleicos.
EP2772431A3 (en) Rotor system shear bearing
WO2009045819A3 (en) Symbiotic biological systems as platforms for sensing, production, and intervention
EP3257951A3 (en) Methods and compositions for identifying and quantifying fungal dna
JP2004358239A5 (pt)

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2604 DE 01/12/2020 QUANTO AO TITULO.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/04/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2717 DE 31-01-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.